PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above 200 Day Moving Average of $0.11

PURE Bioscience, Inc. (OTCMKTS:PUREGet Free Report)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.11 and traded as high as $0.11. PURE Bioscience shares last traded at $0.11, with a volume of 102,800 shares.

PURE Bioscience Price Performance

The company has a debt-to-equity ratio of 3.75, a current ratio of 2.56 and a quick ratio of 2.43. The firm has a market cap of $12.30 million, a P/E ratio of -1.83 and a beta of 0.07. The stock’s 50-day simple moving average is $0.13 and its two-hundred day simple moving average is $0.11.

PURE Bioscience (OTCMKTS:PUREGet Free Report) last posted its quarterly earnings results on Thursday, December 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.72 million during the quarter. PURE Bioscience had a negative return on equity of 717.03% and a negative net margin of 192.12%.

PURE Bioscience Company Profile

(Get Free Report)

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

Recommended Stories

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.